Home/Cytokind/Ben Wang
BW

Ben Wang

Co-Founder, Chief Science Officer

Cytokind

Cytokind Pipeline

DrugIndicationPhase
NB-UVB Home TherapyChronic Skin Conditions (Eczema, Psoriasis)Commercial
NB-UVB for Systemic InflammationMultiple Sclerosis (MS) FatiguePre-clinical / Exploratory
NB-UVB for Immune ModulationPost-Acute COVID-19 / Long COVIDPre-clinical / Exploratory